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Obesity altered T cell metabolism and the response to
infection
William D Green and Melinda A BeckAn epidemic of obesity over the past three decades increases
the risk of chronic and infectious diseases for adults and
children alike. Within the past few years, obesity has been
shown to impair the adaptive immune response to infection
through alterations in T cell functioning. Growing evidence
suggests that perturbations in T cell metabolism drives this
stunted immune response, stemming from nutrient, hormone
and adipokine dysregulation in the obese. In this review, recent
findings in the fields of obesity and T cell mediated immunity
demonstrate a unique relationship between altered
mechanisms of T cell metabolic homeostasis and plasticity of
adaptive immune responses in the obese setting.
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Introduction
The immune response to infection involves a complex
orchestra of diverse cell types, including dendritic cells,
macrophages, natural killer cells, and B and T cells.
As one of the most prominent and critical players in the
response to infection, subsets of T cells range in activity
from supporting the function and activation of other
immune cells, as well as T cells themselves, to producing
pro and anti-inflammatory proteins. Cytotoxic T cell
subsets are instrumental in the elimination of patho-
gen-infected host cells. This diversified set of immuno-
logically adaptive immune cells plays a critical and central
role in combating pathogens. A number of T cell subset
knockout models have demonstrated that removal of T
cells during an infectious challenge often results in higher
rates of morbidity and mortality. For many years, T cell
activation and function was believed to occur from acombination of antigen recognition, subsequent signaling
cascades and micro-environmental cues [1,2]. However,
recent studies have clearly demonstrated that the cellular
metabolism of the T cell is also a key player affecting T
cell differentiation, proliferation, function and its ulti-
mate fate [3,4,5,6–8].
Reports of how metabolic fuels such as glucose, amino
acids and fatty acids elicit distinct metabolic profiles
depending on cell state (naı̈ve, effector or memory)
and subtype (Th1, Th2, Th17, Treg, etc.) [4,9–11], has
led to a revolution in the understanding of T cell driven
immunity. Furthermore, it highlights the metabolic plas-
ticity of T cells to respond to the energetic and biosyn-
thetic demands required to successfully fight infection.
For primers on T cell metabolism, refer to the excellent
reviews by MacIver et al. [4] and Buck et al. [5].
Although T cells respond to antigenic challenge by alter-
ing their metabolic state, what is not as well understood is
how metabolic conditions may alter their ability to func-
tion. One such metabolic condition that may have a
profound effect on T cell function is obesity. Obesity
has classically been characterized as a state of excess
adiposity and is associated with chronic inflammation
and metabolic dysfunction such as hyperglycemia, hyper-
leptinemia and hormone resistance [12]. These uncon-
trolled metabolic conditions can lead to the development
of chronic diseases such as type II diabetes, kidney
disease, cardiovascular disease and specific cancers [13].
However, recent data from our lab and others demon-
strates a link between obesity and increased incidences of
infectious diseases, most likely through impaired cellular
immune responses [13,14].
Considering recent findings on how T cell metabolism
drives cellular function and survival, understanding how
obesity impacts these processes in T cells remains critical.
This review examines recent works in the fields of
obesity and T cell mediated immunity; exploring possible
mechanisms of inflammation, hormone and adipokine
regulation, and senescence to understand the altered
response to infection in obesity through changes in T
cell metabolism.
T cell metabolism supports cell survival and function
T cells display unique metabolic flexibility unlike other
cells in the body. Upon stimulation of the T cell receptor
(TCR) and costimulatory receptors, T cells undergo a
dramatic metabolic shift from a quiescent to activated
state, highlighted by a change from primarily catabolic to 
anabolic metabolism (Figure 1) [4]. This shift from oxi-
dative phosphorylation to glycolysis produces ATP and 
supports the generation of nucleotides and amino acids 
for the production of daughter cells necessary to mount an 
effective immune response [15]. Importantly, this glyco-
lytic shift supports effector functions, which varies 
depending on T cell subtype [3,11,16]. Following clear-
ance of the infection, the majority of effector T cells 
undergo apoptosis with a small subset remaining as long-
lived memory T cells [17,18]. These memory T cells 
revert back to a relatively quiescent catabolic state. How-
ever, unlike their naı̈ve cell counterparts, memory T cells 
quickly respond to antigenic challenge upon re-exposure 
through elevated metabolic activity, increased prolifera-
tion and production of cytokines [19,20].
These different metabolic states of T cells require sig-
naling molecules to support homeostasis, effector func-
tion and survival. Cytokines such as IL-7 and IL-15 
support the catabolic survival functions of naı̈ve and 
memory T cells, respectively [16,21,22]. Other cytokines, 
such as IL-2, support proliferation upon stimulation [23], 
while interferon gamma (IFN-g) promotes pro-inflamma-
tory T cell subtypes like Th1 and cells of innate immu-
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as fatty acids and amino acids to produce ATP through the TCA cycle and 
surveillance and homeostasis. Upon stimulation of the T cell receptor (TCR)
glutamine oxidation while reducing fatty acid oxidation to support cell grow
clearance of the pathogen, the majority of T cells undergo apoptosis with a
dependent on oxidative phosphorylation of fatty acids.inflammatory response once pathogen clearance has
occurred. For example, regulatory T cells (Treg) and
the cytokine IL-10 help to suppress T cell activation
and proliferation [24,25].
Aside from cytokine and growth factor signals, nutrients
and hormone signaling also influence T cell metabolism
[8,23,26]. These signals have been shown to affect
regulatory pathways controlled by enzymes such as the
mammalian target of rapamycin (mTOR) and AMP-acti-
vated protein kinase (AMPK) to influence cell growth/
proliferation or homeostasis [27,28]. In the absence of
these extrinsic signals, T cells lose their ability to main-
tain homeostasis and eventually succumb to apoptosis
through Bcl-2 mediated cell death [7,28].
Obesity impairs the immune response to infection
As of 2014, for the first time in recorded history, obese
adults outnumber underweight adults worldwide, with
the global prevalence of obesity equaling 10.8% in men
and 14.9% in women [29]. In the United States, obese
adults comprise 36.5% of the population [30]. Obesity has
been linked with increased incidences of infectious dis-
eases, including periodontal infections, influenza, bacte-
rial pneumonia, nosocomial and surgical site infections,
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 cells utilize oxidative respiration of glucose-derived pyruvate as well
electron transport chain. This energy production supports immune
 and costimulatory receptors, T cells upregulate glycolysis and
th, differentiation and the production of daughter cells. Following
 subset surviving as memory T cells, which return to a quiescent state
shown to impair immunological responses in both adults
and children [32–34].
Following the first influenza pandemic of the 21st cen-
tury, obesity was identified as an independent risk factor
for increased morbidity and mortality from pandemic
H1N1 infection [31]. Our laboratory studied the response
to influenza vaccination in obese adults and found that
increasing BMI was associated with greater declines in
influenza-specific antibody titers one-year post vaccination
[33]. In addition, influenza-stimulated T cells from obese
adults were less functional and less activated compared
with T cells from vaccinated healthy weight adults [35].
Obesity has been shown to reduce circulating levels of gd
T cells, as well as impair their function through reduced
IL-2 receptor expression and IFN-g production [36].
Moreover, obesity has been implicated in reduced
function of Treg cells in obese patients with asthma
[37]. Finally, growing evidence suggests obesity impairs
immune responses to vaccines such as hepatitis B (HB),
hepatitis A (HA), rabies and tetanus, as well as increases
risk of several bacterial infections [38].
Despite this growing evidence supporting the notion that
obesity impairs immunological responses to infection, it is
worth noting that some studies have found a protective
effect of obesity against infection. Roth et al., in their
review of over 20 epidemiological studies, found that
obesity was associated with better outcomes from infec-
tions such as tuberculosis, community-acquired pneumo-
niaandsepsis [39]. They arguethat aspects of themetabolic
syndrome often found in obesity provide an advantageous
niche for immune cells to fight off infection. While there is
controversy between findings on obesity’s impact on the
immune response to infection, it is important to note that
obesity is a multifactorial condition that impacts a variety of
tissue and organ systems.
Obesity alters the metabolome during infection
Studies using murine models of obesity have shown great
similarity to obesity in humans, providing a translational
model to study this complex condition [40]. Recent
studies have shown altered metabolic profiles in diet-
induced and genetically obese mice following influenza
virus challenge in vivo. Using 1H NMR and global
liquid chromatography-mass spectrometry, Milner et al.
reported specific alterations in the metabolic profiles of
influenza-infected diet-induced obese mice when com-
pared with infected lean mice in serum, liver, lung,
mesenteric white adipose tissue, urine, feces and bronch-
oalveolar lavage fluid [41,42]. Changes in metabolites
included increased levels of fatty acid, cholesterol and
phospholipids in lung tissues isolated from obese mice
compared to lean mice, correlating with increased lung
damage and mortality observed in the infected obese
mice [42].Notably, obese mice showed significant fold increases in
glutamyl-proline, tetrahydrocortisol, 3-hydroxybutyric
acid and numerous acyl-carnitine metabolites in lung
tissues [42], suggesting differential metabolism in these
tissues may be driving immune dysregulation in the
influenza-infected lung. Additionally, diet-induced obese
mice also had a 55-fold increase in p-cresol sulfate con-
centrations in lungs at 4 days post infection compared to
lean mice [42]. P-cresol sulfate, a metabolite produced
by gut microbiota during secondary metabolism of
p-cresol, accumulates during kidney failure and can impact
cell function [42]. This increase in secondary metabolites
in obese mice suggests that obese microbiome may differ
from lean, and thus contribute to differences in immune
function.
In order to differentiate between the dietary vs. obesity
effects, mice lacking hypothalmic leptin receptors
(LepRH/) were utilized in the influenza infection
model. LepRH/ knockout mice were established by
crossing fully floxed leptin receptor mice with Cre trans-
gene expressing C57BL/6J-Tg(Nkx2-1-cre)2S mice
driven by the Nkx2.1 promoter. These transgenic mice
lacked leptin receptor signaling in hypothalamic neurons,
resulting in obesity from excess consumption of a low fat
chow diet; therefore removing the influence of high fat
diet on immune function. Compared to lean controls
(LepRHFlox/Flox consuming an identical diet), obese mice
that gained weight on the chow diet also exhibited altered
metabolic profiles. Similar to high fat fed diet-induced
obese mice, the LepRH/ obese mice had altered fatty
acid, cholesterol and nucleic acid metabolites in urine and
lung tissues following influenza virus infection [42].
Again, these variations in metabolites correlated with
greater lung pathology and inflammation, as well as
reduced levels of quiescent and activated CD4+ and Treg
cells in the lung and bronchoalveolar lavage fluid during
the immune response to influenza virus infection [42].
These studies suggest that obesity itself, not the diet,
alters metabolites both in circulation and in tissue specific
regions impacted by infection. This work supports our
proposal that obesity alters the metabolic landscape of the
host, thus impairing T cell function, leading to increased
susceptibility to infectious disease.
Adiopocytes in the obese state promote inflammatory
T cell activation through altered metabolism
Another theory as to how obesity impairs the T cell
response to infection involves the distorted cytokine
and adipokine milieu brought about by excess adiposity.
Leptin, a hormone involved in energy homeostasis, has
been shown to be essential for glucose uptake in effector
T cells [26]. Upregulation of Glut1 receptors by leptin
signaling under normal conditions represents a bioener-
getic advantage for T cells to prevent suppressed prolif-
erative and functional responses when glucose concen-
trations become limited [7,23,26]. However, in obesity,
when leptin secretion becomes systemic and chronic, 
leptin signaling may lead to altered CD4+ T cell differ-
entiation. Leptin signaling has been shown to promote 
pro-inflammatory T cell subtypes, Th1 and Th17 
[26,43,44], suggesting leptin plays a critical role in 
the development of an inflammatory adipose tissue 
microenvironment. Leptin’s role in modulating T cell 
repertoires, leading to inflammatory adipose tissue micro-
environments is further supported with the identification 
that pro-inflammatory CD8+ T cells precede adipose 
tissue macrophage (ATM) infiltration in visceral adipose 
tissue, with marked declines in CD4+ helper T cell and 
Treg cell populations in obese mice compared to lean [45].
Infiltration of T cells in adipose tissue has received 
attention for its suggested role in the development of 
insulin resistance [46]. Recent findings by Morris et al. 
identified a mechanism by which ATMs function as 
antigen presenting cells (APCs) to regulate the activation 
of CD4+ T cells in mice [47]. This finding, reproduced by 
Cho et al., identified a novel MHCII-dependent activa-
tion loop between CD4+ T cells and ATMs which sup-
ports T cell driven metainflammation in adipose tissue in 
mice [48].
However, large human adipocytes were also shown to 
activate CD4+ T cells through MHCII-upregulation, 
thereby acting as APCs to stimulate T cell inflammatory 
effector functions [49]. This activation of adipose tissueFigure 2
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disruption of normal T cell metabolism, resulting in impaired cellular function
profile of T cells, impacting their feedback of cytokine secretion and functio
epigenetic changes, or metabolite influence from obese microbiota has yet associated T cells by MHCII-mediated APCs and leptin
costimulation supports the notion of an inflammatory
microenvironment observed in obese adipose tissue.
These findings suggest the possibility that obesity leads
to suppressed T cell response to infection through altered
T cell populations caused by premature activation to pro-
inflammatory T cell subtypes.
Adipocytes in the obese state promote T cell
senescence
Senescence, typically associated with aging, is described
as a fate in which cellular proliferation becomes halted
but metabolic activity and function remains [50]. This
cell phenotype represents a state of cellular exhaustion,
supported by chronic activation of Akt and mTOR,
thereby supporting cytokine production but limiting pro-
liferation [50,51]. Recently, obesity was proposed to
increase T cell senescence in visceral adipose tissue
(VAT) of high fat fed obese mice [52]. These mice
displayed increased accumulation of CD153+PD-
1+CD44+CD4+ T cells in VAT, resembling the activity
of senescent associated T cells, with increased osteopon-
tin secretion and VAT inflammation [52]. Previously,
osteopontin has been shown to be a Th1 promoting
cytokine that supports pro-inflammatory function [53].
This increased production of PD-1 (programmed cell
death-1), an exhaustion/tolerance marker, [54], signals
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on in obesity. Nutrients, leptin and inflammation signals cause a
s. Long-term exposure to these extrinsic signals alters the metabolic
nal response to infection. Whether or not long-term exposure results in
to be determined.
of PD-1 as an immune regulator of TCR activation in
effector T cells is evidenced by the establishment of PD-
1 expressing CD8+ effector memory T cells, and not
central memory T cells [55]. Furthermore, strength of
PD-1 expression is tied to signaling activation and effec-
tor function in T cells, such that high expression of PD-1
is needed for cell exhaustion but only low levels are
required to disrupt some functions such as IL-2 or
TNF-a secretion [56].
Finally, CD4+ T cell metabolism was shown to alter PD-1
expression in mice cultured with glucose versus galactose
[57]. This alteration in T cell metabolism from aerobic
glycolysis to respiration resulted in differences in glycer-
aldehyde 3-phosphate dehydrogenase expression, corre-
lating with PD-1 expression and subsequent impairment
in IFN-g production [57]. This connection between
aerobic glycolysis of CD4+ T cells and PD-1 expression
demonstrates a novel mechanism through which T cell
function is influenced by nutrition. How long-term expo-
sure to obesogenic conditions impact gene expression
remains unresolved. However, some recent studies sug-
gest that obesity can lead to the hypermethylation of
lymphocyte DNA in humans and animals [58,59], thereby
proposing an epigenetic component that supports the
conditions of obesity associated T cell senescence.
Conclusion
Despite the lack of direct evidence linking obesity and
altered T cell metabolism with impaired immune
response to infection, foundations from several studies
over recent years support the hypothesis that obesity
disrupts T cell metabolism, resulting in impaired func-
tion. Altered metabolism of the obese host has been
shown both in the steady state and during infection.
Hormone resistance, inflammation and alterations in
nutrient levels all influence T cell activation, function
and survival. A surfeit of nutrients such as glucose and
fatty acids, along with excess leptin production in the
obese state, may elicit the activation of T cells in the
absence of specific pathogens, thus, skewing naı̈ve and
memory cells towards inflammatory Th1 & Th17 sub-
types, while reducing anti-inflammatory Treg repertories
(Figure 2). The response to infection in an obesogenic
environment most likely would result in disrupted T cell
metabolism through increased glycolytic and oxidative
flux and cause impaired T cell response by promoting
inflammation and reducing anti-inflammatory immune
surveillance. How chronic exposure to excess nutrients,
hormones and inflammation influences gene regulation in
lymphocytes remains unknown. Obesity as a complex
multifactorial condition represents a growing and serious
health problem, warranting further study.
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